Clinical Trial Update: Efficacy and Safety of Sintilimab Combined with Platinum-containing Double-agent Chemotherapy in First-line Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer in Elderly Patients

View source ↗

Summary

Clinical trial status update indicates an ongoing first-line study of sintilimab combined with platinum-containing double-agent chemotherapy for elderly patient…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Platinum-containing double-agent chemotherapy
• Sintilimab (sintilimab)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Non-Small Cell Lung Cancer | Status: ENROLLING_BY_INVITATION